自动化胰岛素剂量指导以优化2型糖尿病患者的胰岛素管理:多中心随机对照试验
相关实验视频
Updated: Jan 28, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
Richard M Bergenstal1, Mary Johnson1, Rebecca Passi1
1International Diabetes Center, Minneapolis, MN, USA.
Lancet (London, England)
|February 28, 2019
概括
与专业人士的支持相比,d- Nav胰岛素指导系统在2型糖尿病患者中显著改善了血糖控制. 这种自动化系统可提供安全有效的胰岛素定位,提高患者的治疗效果.
科学领域:
- 内分泌学
- 糖尿病管理
- 医疗器械
背景情况:
- 胰岛素治疗需要经常调整剂量以获得最佳效果,这对于临床医生来说往往是不切实际的,导致胰岛素定位差距.
- d- Nav胰岛素指导系统是一种用于血糖监测,模式分析和自动胰岛素剂量确定的手持设备.
- 这项研究评估了d-Nav系统与专业的支持相结合,是否比专业的支持更有效管理2型糖尿病.
研究的目的:
- 在2型糖尿病患者中,将d- Nav胰岛素指导系统加上医疗保健专业人员的支持与单独的医疗保健专业人员的支持进行比较.
- 在6个月内评估对糖化血红蛋白 (HbA1c) 水平的影响.
- 评估干预的安全性,特别是低血糖事件的频率.
主要方法:
- 一项多中心,随机,受控的研究,涉及美国三个中心的181名2型糖尿病患者.
- 参与者被随机分配 (1:1) 接受专业支持 (干预) 或专业支持 (控制) 的d-Nav系统.
- 主要结论是HbA1c从基线到6个月的平均变化;安全性是根据低血糖事件的频率进行评估的.
主要成果:
- 干预组的平均HbA1c降低为1. 0%,而对照组的平均降低为0. 3% (p< 0. 0001).
- 结合专业的支持,d-Nav系统显著提高了血糖控制.
- 干预组和对照组的低血糖事件发生频率相似 (两组均为0. 29事件/ 月).
结论:
- 自动化胰岛素定位指导与医疗保健专业人员的支持相结合,可为2型糖尿病患者提供卓越的血糖控制.
- 这种方法有助于安全有效的胰岛素管理.
- 建议在大型医疗保健系统进行进一步评估,以确认发现并评估成本效益.
相关概念视频
Insulin Formulations: Types and Delivery
717
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
717
Insulin: Dosing Regimen and Adverse Effects
745
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
745
Diabetes Mellitus: Type 2 and Gestational
4.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.7K
Insulin Secretory Vesicles
6.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.8K
Insulin: The Receptor and Signaling Pathways
3.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.0K
Insulin: Biosynthesis, Chemistry, and Preparation
1.3K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.3K

